State of New Jersey Common Pension Fund D Has $17.97 Million Holdings in Thermo Fisher Scientific Inc (TMO)

State of New Jersey Common Pension Fund D grew its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 11.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 95,000 shares of the medical research company’s stock after acquiring an additional 10,000 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Thermo Fisher Scientific were worth $17,974,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. AXA raised its position in shares of Thermo Fisher Scientific by 12.2% during the 1st quarter. AXA now owns 631,157 shares of the medical research company’s stock worth $96,946,000 after purchasing an additional 68,557 shares during the last quarter. MAI Capital Management raised its position in shares of Thermo Fisher Scientific by 72.5% during the 1st quarter. MAI Capital Management now owns 3,287 shares of the medical research company’s stock worth $505,000 after purchasing an additional 1,381 shares during the last quarter. Covington Investment Advisors Inc. raised its position in shares of Thermo Fisher Scientific by 3.4% during the 1st quarter. Covington Investment Advisors Inc. now owns 14,158 shares of the medical research company’s stock worth $2,175,000 after purchasing an additional 460 shares during the last quarter. BB&T Securities LLC raised its position in shares of Thermo Fisher Scientific by 4.4% during the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after purchasing an additional 3,819 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan raised its position in shares of Thermo Fisher Scientific by 1.0% during the 1st quarter. Municipal Employees Retirement System of Michigan now owns 12,750 shares of the medical research company’s stock worth $1,958,000 after purchasing an additional 130 shares during the last quarter. Institutional investors and hedge funds own 83.78% of the company’s stock.

In related news, VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the transaction, the vice president now owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the transaction, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The disclosure for this sale can be found here. Insiders have sold a total of 60,420 shares of company stock valued at $11,308,477 in the last ninety days. 0.49% of the stock is currently owned by corporate insiders.

Several research analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, September 18th. Barclays PLC restated an “overweight” rating and set a $215.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Monday, September 25th. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, Morgan Stanley restated an “overweight” rating and set a $220.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and an average target price of $205.71.

TRADEMARK VIOLATION WARNING: “State of New Jersey Common Pension Fund D Has $17.97 Million Holdings in Thermo Fisher Scientific Inc (TMO)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.com-unik.info/2017/11/19/state-of-new-jersey-common-pension-fund-d-has-17-97-million-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Shares of Thermo Fisher Scientific Inc (TMO) opened at $190.17 on Friday. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $201.20. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The firm has a market cap of $76,257.22, a P/E ratio of 20.90, a PEG ratio of 1.74 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter last year, the company posted $2.03 EPS. sell-side analysts forecast that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. Thermo Fisher Scientific’s payout ratio is currently 10.19%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit